Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ICAM1 | P05362 | 4/20 | 0.37 |
| ▸ | SELE | P16581 | 4/20 | 0.37 |
| ▸ | BRAF | P15056 | 10/20 | 0.34 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
| ▸ | RHEB | Q15382 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7882375 | 0.90 | FFAR1 (0.39) | RHEBFFAR1KDM4E | |
| SCHEMBL7880924 | 0.89 | FFAR1 (0.36) | ICAM1SELEBRAFVCAM1RHEB | |
| SCHEMBL7884689 | 0.89 | SMN1; SMN2 (0.43) | BRAFKDM4ESMN1; SMN2 | |
| SCHEMBL7877775 | 0.89 | MET (0.37) | BRAFKDR | |
| Hydrochloric Acid SCHEMBL7881497 | 0.88 | FFAR1 (0.36) | ICAM1SELEBRAFVCAM1RHEB | |
| SCHEMBL7881882 | 0.87 | ICAM1 (0.35) | ICAM1SELEBRAFVCAM1RHEB | |
| SCHEMBL7880732 | 0.87 | FFAR1 (0.35) | ICAM1SELEBRAFSCN9ARHEB | |
| SCHEMBL7881036 | 0.86 | ESRRA (0.35) | ICAM1SELEBRAFVCAM1RHEB | |
| SCHEMBL7877749 | 0.85 | MEN1 (0.38) | KDRMAPT | |
| SCHEMBL7882210 | 0.85 | BRAF (0.33) | BRAFKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6248772-B1 | HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2001-06-19 | — | — | US | disclosed |
| US-6169107-B1 | USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS | SUMITOMO PHARMACEUTICAL CO., LTD. (JP) | 2001-01-02 | — | — | US | disclosed |
| EP-0708091-A2 | Indoloylguanidine derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1996-04-24 | — | — | EP | disclosed |